I Live to Conquer Cancer
Cancer treatment advances are transforming cancer care and giving hope to the millions of Americans who face a cancer diagnosis each year. This progress would not be possible without the strong support provided by the National Cancer Institute (NCI) and the passionate work of cancer researchers who are finding new ways to diagnose, prevent, and treat cancer to improve outcomes for people with cancer.
Through the “I Live to Conquer Cancer” campaign, ASCO is putting a human face on those who have dedicated their lives to clinical cancer research and the patients who inspire them to continue their work against cancer.
Read the stories below and visit the I Live to Conquer Cancer campaign.
Dec 05, 2019
Dr. Dizon aims to inspire colleagues with new ideas for whole-person care in a complex, fast-changing health care landscape.
Sep 23, 2019
Dr. Rodriguez lives to conquer cancer and make cancer care available to everyone who needs it, regardless of location or ability to pay for treatment.
Sep 23, 2019
Dr. Graff is conquering cancer so that all patients can focus on pursuing their goals and living life to the fullest.
Feb 19, 2019
Dr. Jain lives to conquer cancer because she knows that enrolling on a clinical trial can change a patient's life.
Dec 10, 2018
Dr. Knoll lives to conquer cancer because treating patients who are suffering is truly a privilege.
Nov 19, 2018
Dr. Sarkar is conquering cancer by conducting research to better understand the processes that drive the development of liver cancer.
Nov 13, 2018
As a pediatric neuro-oncologist, Dr. Hwang lives to conquer cancer for every child, and he is continually reminded of why he cannot stop working in this field.
Nov 07, 2018
Progress against cancer requires strong, continued support for NIH and NCI.
Sep 04, 2018
Every day Dr. Alan Lyss pins a bright red “Research Cures Cancer” button on the lapel of his white coat as a reminder of his life’s mission: to save and improve the lives of his patients through research.
Aug 08, 2018
Dr. Copur is conquering cancer by helping patients in Nebraska access high-quality, high-priority NCI clinical trials.